Financial, market and economic news

With the World Awaiting Vaccine Supply for 7,5 Billion People, the Drug Packaging Market Remains Optimistic With a 13,2% Spike in Revenues

New York, Nov. 20, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Pharmaceutical Packaging Equipment Industry” – https://www.reportlinker.com/p05799352/?utm_source=GNW
2% spurt in revenues for the year 2020 and thereafter reach US$15.2 billion by the year 2027, trailing a post COVID-19 CAGR of 9.3% over the analysis period 2020 through 2027. Despite the optimistic outlook for the market, the pharmaceutical industry is not without its share of challenges. The industry is witnessing disruptions in supply of active materials and ingredients, with production dependent on raw materials from China impacting most countries. The rude shock rendered by the pandemic has awakened the focus on self-sufficiency in production supply chain. Drug R&D, scheduled approvals and launches & routine production of non-COVID drugs are showing signs of being impacted. As a result of lockdowns and consumption of healthcare resources for COVID-19, TB & its deadly allies like HIV & malaria are making a comeback. Over 7 million additional cases of TB are forecasted by the end of 2020. Drug production faces the pressure of pent-up demand, and challenges in scaling production to meet the increased demand. In a fairly mixed outlook, drug packaging equipment will benefit from the search for drugs, therapies & vaccines for COVID-19 & post virus focus on public health & innovative drug development.

Several companies have started to provide antiviral, sterile packaging to mitigate concerns associated with the viral exposure. These solutions are intended to protect frontline workers engaged in dealing with the rapidly increasing cases of COVID-19. The pandemic has not only pushed demand for healthcare packaging such as pumps, rigid plastic and flexible blister foils, but has also increased the risk of transmission of the virus through pharmaceutical packaging surfaces. Mounting concerns regarding viral exposure is largely due to the ability of the virus to survive on packaging surfaces for longer periods. These concerns are poised to benefit antiviral, sterile packaging formats. Plastics, against this backdrop, are emerging as a perfect material for antiviral and sterile packaging. Based on its high versatility and barrier properties, plastic is anticipated to emerge as the preferred option for these packaging solutions. Moreover, antiviral biopolymers, mainly products reinforced with specific active drug components, are anticipated to witness immense popularity owing to their eco-friendly nature and low toxicity. These products present an effective solution to reduce the contamination risk and ensure handling safety. Several companies are also betting on NO2-based sterilization technology for achieving product differentiation. The technology offers benefits of ultra-low temperature process, low pressure requirements and faster cycle times. In addition, plastic presents an ideal solution for ensuring longer shelf life of pharmaceutical products, which is slated to benefit the packaging material during the pandemic.

In support of the world’s focus on development of COVID-19 vaccine, pharmaceutical packaging market is also scaling up operations to keep pace with the ongoing efforts in the space. Companies engaged in development of COVID-19 vaccines are signing agreements with packaging companies for manufacturing syringes and vials to package COVID-19 vaccine. Moderna for instance announced a collaborative deal with Catalent in June 2020 for providing vial filling and packaging for initial batch of 100 million doses of vaccine from its US facility in Indiana. The company is expected to produce around 500 million to 1 billion doses annually, starting in 2021 from its US-based production facility, through a strategic partnership with Lonza, enhancing the need for packaging solutions. Presently, around 142 experimental vaccines are under studies, focusing on diverse technologies, to efficiently assess clinical outcomes across board. Irrespective of the diverse platforms, the development haste is all set to augur well for the production of vaccine in the near term. About 13 vaccines have entered human trials to test the safety and efficacy of the vaccine on healthy volunteers, while 129 are in pre-clinical animal trial studies. Moderna, AstraZeneca, CanSino Biologics, and Pfizer are expected to be released in the first wave during second half of 2020 and first quarter of 2021. The second wave will see Johnson & Johnson, GlaxosmithKline/Sanofi in the second half of 2021. The production of vaccines would start even before the regulatory approval from third quarter of 2020. Commercial availability of the vaccine would start between fourth quarter 2020 to early 2021. Scaling up manufacturing facilities, growing global efforts in terms of non-profit public-private partnerships ensuring equitable access to vaccine supplies, greater international collaboration for mapping safety data and vaccination protocols, and strategic financing are all set to boost the prospects of successful development and utilization of COVID-19 vaccine in the near term.

Competitors identified in this market include, among others,

  • Accutek Packaging Equipment Companies, Inc.
  • ACG Worldwide Pvt., Ltd.
  • IMA SpA
  • Korber AG
  • Marchesini Group SpA
  • Mg2 Srl
  • MULTIVAC Sepp Haggenmuller SE & Co. KG
  • Optima Packaging Group GmbH
  • Robert Bosch GmbH
  • Romaco Pharmatechnik GmbH
  • Uhlmann Group
  • Vanguard Pharmaceutical Machinery, Inc.

Read the full report: https://www.reportlinker.com/p05799352/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE I-1

II. EXECUTIVE SUMMARY II-1

1. MARKET OVERVIEW II-1
COVID-19 Impact on Pharmaceutical Packaging Market II-1
Exhibit 1: Growing COVID-19 Cases and Efforts to Develop
Vaccines Presents Opportunity for Pharmaceutical Packaging
Equipment Market: Top Countries Ranked by Number of COVID-19
Cases II-2
COVID-19 to Restructure the Pharmaceutical Supply Chain Management II-2
Pharmaceutical Companies Devise Innovative Strategies for
Streamlining Supply Chain Networks II-3
Pharmaceutical Packaging Players Gear Up with Sterile,
Antiviral Packaging to Deal with COVID-19 Challenge II-4
Unprecedented Global Push to Expedite COVID-19 Vaccine
Development to Spur Demand for Packaging Products, Propel
Growth in Packaging Equipment II-5
Exhibit 2: COVID-19 Vaccines in Pipeline by Technology and
Clinical Stage II-6
A Prelude to Pharmaceutical Packaging II-6
An Introduction to Pharmaceutical Packaging Equipment II-7
Global Pharmaceutical Packaging Equipment Market: Prospects &
Outlook II-8
Advancements in Pharmaceutical & Biopharmaceutical Industries
Fuel Growth Packaging Equipment Market II-10
Primary Packaging Equipment Segment Leads Market II-11
Liquids Packaging Equipment Dominates Global Market II-12
Europe Continues to Rein Global Pharmaceutical Packaging
Equipment Market II-12
Competition II-13
Packaging Equipment Providers Rise Up to Address Evolving Needs
and Challenges Faced by Pharmaceutical Industry II-14

2. FOCUS ON SELECT PLAYERS II-17

3. MARKET TRENDS & DRIVERS II-19
Strong Rise in Pharmaceutical Sales to Drive Demand for Glass
Packaging Solutions II-19
Exhibit 3: Global Prescription Drug Sales (In US$ Billion) for
the Years 2017, 2019, 2021, 2023 & 2025 II-20
Rapid Growth of Generic Drugs Drives Demand for Pharma
Packaging Equipment II-20
Exhibit 4: Global Generic Drugs Market Size (in $ Billion) for
the Years 2016, 2019, 2020 & 2025 II-21
Increasing Significance of Biologic Drugs Fuels Innovations in
Packaging and Delivery Techniques, Supporting Demand for
Packaging Equipment II-22
Exhibit 5: Global Biologic Drugs Market Size (in US$ Billion)
for the Years 2019, 2022 & 2025 II-23
Increasing Sales of OTC Drugs Presents an Opportunity for
Pharma Packaging Equipment Makers II-24
Exhibit 6: Global OTC Drugs Market Breakdown by Product (in %):
2020E II-24
Aging Population & Increasing Burden of Chronic Diseases Spurs
Pharma Product Sales, Driving Market Growth II-25
Exhibit 7: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050 II-26
Exhibit 8: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 II-27
Exhibit 9: World Diabetes and Population Statistics (2019, 2030
& 2045) II-27
Market Poised to Benefit from the Rapid Growth of
Pharmaceutical Contract Manufacturing Activity II-28
Exhibit 10: Global Pharmaceutical Contract Manufacturing Market
Size (in US$ Billion) for 2019, 2022 and 2025 II-29
Contract Packaging Trend Augurs Well for the Pharma Packaging
Equipment Market II-30
With Emerging Economies Emerging as Hubs of Pharma
Manufacturing Activity, Growth Potential in Store for
Equipment Companies II-30
Trends in Pharmaceutical Sector Drive the Need for
Collaboration between Industry and Equipment Providers II-31
OEE Makes Way into the Pharma Sector II-32
Serialization Drives New Design Developments in Pharma Sector II-33
Blister Packaging: The Mainstay of Pharmaceutical Packaging II-34
Blister Packaging on Rise in the Pharmaceutical Sector II-35
Increasing Use of Blow/Fill/Seal Technology in Pharmaceutical
Packaging Applications II-36
Demand Remains Consistent for Aseptic & Sealing Equipment in
Pharmaceutical Industry II-37
Rise of Smart Packaging in Pharmaceutical Sector Influences
Equipment Demand II-37
Demand Rises for Integrated and Flexible Packaging Equipment in
Pharma Industry II-38
Automated Packaging Equipment Support Market Growth II-39
Labeling & Serialization Equipment Segment Benefits from
Increased Focus on Preventing Counterfeiting of Drugs II-39
Equipment for Small Batch Production & Research Purposes Find
Favor II-41
Evolving Technologies and Trends Impact Growth in
Pharmaceutical Manufacturing & Packaging Equipment Market II-41
Shift Towards Specialized Therapies and Biopharmaceuticals
Influences Market II-43
Rising Demand for Equipment with Complex, Integrated Capabilities II-44
Equipment Manufacturers Striving to Address Major Industry
Challenges II-45
Increasing Use of Robots II-45
Evolving and Complex Drug Formulations Lead to Packaging
Equipment Innovations II-45 …

Full story available on Benzinga.com

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy